Methylation of the calcium channel regulatory subunit alpha 2 delta-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Calcium is an important intracellular messenger that mediates many biological processes that are relevant to the
malignant process. Calcium ion channels are key in controlling the intracellular calcium, and little is known about their role in human
cancer.
METHODS: We used qPCR and pyrosequencing to investigate expression and epigenetic regulation of the calcium channel regulatory
subunit a2d-3 (CACNA2D3) in breast cancer cell lines, primary cancers and metastatic lesions.
RESULTS: Expression of CACNA2D3 mRNA is regulated in breast cancer cell lines by methylation in the CpG island located in the
50 regulatory region of the gene. Expression is upregulated by azacytidine (AZA) in cells with CpG island methylation but unaffected
in cells lacking methylation. In primary breast carcinomas, methylation is more common in cancers, which subsequently relapse
with loco-regional and, particularly, visceral metastatic disease in both oestrogen receptor-a (ER)-positive and -negative cases.
Furthermore, CACNA2D3 CpG island is frequently methylated in breast cancer that has metastasised to the central nervous system.
CONCLUSION: Methylation-dependent transcriptional silencing of CACNA2D3 may contribute to the metastatic phenotype of breast
cancer. Analysis of methylation in the CACNA2D3 CpG island may have potential as a biomarker for risk of development of
metastatic disease.
malignant process. Calcium ion channels are key in controlling the intracellular calcium, and little is known about their role in human
cancer.
METHODS: We used qPCR and pyrosequencing to investigate expression and epigenetic regulation of the calcium channel regulatory
subunit a2d-3 (CACNA2D3) in breast cancer cell lines, primary cancers and metastatic lesions.
RESULTS: Expression of CACNA2D3 mRNA is regulated in breast cancer cell lines by methylation in the CpG island located in the
50 regulatory region of the gene. Expression is upregulated by azacytidine (AZA) in cells with CpG island methylation but unaffected
in cells lacking methylation. In primary breast carcinomas, methylation is more common in cancers, which subsequently relapse
with loco-regional and, particularly, visceral metastatic disease in both oestrogen receptor-a (ER)-positive and -negative cases.
Furthermore, CACNA2D3 CpG island is frequently methylated in breast cancer that has metastasised to the central nervous system.
CONCLUSION: Methylation-dependent transcriptional silencing of CACNA2D3 may contribute to the metastatic phenotype of breast
cancer. Analysis of methylation in the CACNA2D3 CpG island may have potential as a biomarker for risk of development of
metastatic disease.
Date Issued
2012-05-29
Date Acceptance
2012-04-26
Citation
British Journal of Cancer, 2012, 107 (2), pp.375-381
ISSN
1532-1827
Publisher
Cancer Research UK
Start Page
375
End Page
381
Journal / Book Title
British Journal of Cancer
Volume
107
Issue
2
Copyright Statement
© 2012 Cancer Research UK This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the
license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
license terms will switch to a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
breast cancer
metastasis
calcium channels
epigenetics
SRC-3/AIB1 COACTIVATOR
GASTRIC-CANCER
CELL CARCINOMA
GENE
IDENTIFICATION
APOPTOSIS
CLONING
TARGET
REGION
CA2+
Publication Status
Published